New study identifies 87 genes linked to AMD

Posted: Friday 26 April 2024

Researchers at the National Eye Institute in the USA have discovered 87 genes in retinal cells that could be affected by environmental factors which may influence the risk of developing age-related macular degeneration (AMD).

Find out more

Macular Society partners with UK’s largest health research programme

Posted: Friday 5 April 2024

The Macular Society is proud to announce a new partnership with Our Future Health, a groundbreaking initiative aimed at revolutionising research into health conditions such as age-related macular degeneration (AMD).

Find out more

Home monitoring for patients with AMD

Posted: Wednesday 3 April 2024

Health tech startup OKKO Health has shared new insights from its UK research study on home monitoring for age-related macular degeneration (AMD). The study is being carried out in collaboration with the Macular Society.

Find out more


‘Regular injections essential in maintaining vision’

Posted: Wednesday 27 March 2024

Early diagnosis, prompt initial treatment, and regular injections help stabilise vision in most eyes with wet age-related macular degeneration (AMD), according to a new report published by the Royal College of Ophthalmologists

Find out more

All you need to know about implantable magnifying lenses for macular disease

Posted: Monday 25 March 2024

Intraocular lenses (IOLs) were the focus of our My Macular and Me webinar in March, as Dr Julie Silvestri shed light on the potential of these devices, which aim to improve vision for people living with sight loss.

Find out more

Increased dose of Eylea to extend treatment intervals

Posted: Friday 1 March 2024

Renowned retinal specialist Dr Kenneth Fan has called the higher approved dose of Eylea for patients with wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO), “a pivotal moment” for the treatment of these conditions.

Find out more

Light grey eye close up

Encouraging results from light therapy study for dry AMD

Posted: Friday 1 March 2024

Early results from a study assessing the effectiveness of the Valeda Light Delivery System for treating dry age-related macular degeneration (AMD), have shown promise.

Find out more

Nurse Looks Into Eyes Of Elderly Patient

Patients reveal communication gaps in diagnosis

Posted: Monday 5 February 2024

Patients have highlighted noticeable gaps in communication when they are first diagnosed with macular disease, or if they are considered at risk of developing the condition.

Find out more

Generic Drug Image

Another new drug offers hope for Stargardt patients

Posted: Monday 29 January 2024

Another drug to potentially treat Stargardt has shown positive results in slowing down the progression of the disease in a recent trial.

Find out more

Professor Mike Cheetham and team

‘We’re hoping our research can lead to potential treatments’

Posted: Wednesday 20 December 2023

A groundbreaking research project is underway, focusing on screening a library of already licensed drugs to potentially treat Stargardt disease.

Find out more

World Geographic Atrophy Day logo

World Geographic Atrophy Day raises awareness of common condition

Posted: Tuesday 5 December 2023

The first-ever World Geographic Atrophy Day raises awareness of the condition and the five million people living with it across the globe.

Find out more

Macular disease under the spotlight at Conservative conference

Posted: Wednesday 25 October 2023

The Macular Society's director of research took to the stage at the Conservative Party Conference earlier this month to shine a light on the need to improve healthcare, especially for people living with macular disease.

Find out more